肿瘤病人外周血DNA检测的意义
被引量:3
Significance of plasma or serum tumor DNA detection in patients with cancer
摘要
肿瘤病人血循环中DNA的量较一般人明显增多 ,而且从中可检测到肿瘤相关基因的特征性改变 ,可用于协助诊断 ,并作为预测预后及疗效观察的指标 。
出处
《国外医学(肿瘤学分册)》
2001年第4期268-270,共3页
Foreign Medical Sciences (Cancer Section)
参考文献10
-
1Leon SA,Shapiro B,Sklaroff DM,et al.Free DNA in the serum of cancer patients and the effect of therapy[].Cancer Research.1977
-
2Mayall F,Jacobson G,Wilkins R,et al.Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma[].Journal of Clinical Pathology.1998
-
3Chen Xq,Stroun M,Magnenat JL,et al.Microsatellite alterations in plasma DNA of small cell lung cancer patients[].Nature Medicine.1996
-
4Wong IH,Lo YM,Zhang J,et al.Detection of aberrant P16 methylation in the plasma and serum of liver cancer patients[].Cancer Research.1999
-
5Anker P,Lefort F,Vasioukhin V,et al.K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer[].Gastroenterology.1997
-
6Castells A,Puig P,Mora J,et al.K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance[].Journal of Clinical Oncology.1999
-
7Sozzi G,Musso K,Ratcliffe C,et al.Detection of microsatellite alteration in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis[].Clinical Cancer Research.1999
-
8Esteller M,Sanchez Cespedes M,Rosell R,et al.Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patient[].Cancer Research.1999
-
9Giacona MB,Ruben GC,Iczkowski KA,et al.Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls[].Pancreas.1998
-
10Kink GD,Camus Randon AM,Mendy M,et al.Ser-249 p53 Mutations in plasma DNA of patient with hepatocellular carcinoma from The Gambin[].Journal of the National Cancer Institute.2000
同被引文献18
-
1任宁,钦伦秀.外周血DNA及其遗传学改变与肿瘤转移复发[J].实用肿瘤杂志,2005,20(4):283-285. 被引量:2
-
2Sheehana M, Kallakuryb VE, Sheehana E, et al. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Hum Pathol, 2005,36:1204-1209.
-
3Maounis NF, Chorti M, Apostolakis E, et al. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers. Cancer Detect Prey, 2006,30:507-514.
-
4Korabiowska M, Cordon-Cardo C, Buschmann N, et al.Comparison of DNA ploidy status and DNA ploidy-related parameters in malignant melanoma tissue microarrays and full sections. Hum Pathol, 2004,35:887-891.
-
5Fizazi K, Morat L, Chanveinc L, et al. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity. Ann Oncol, 2007,18:518-521.
-
6Yao F, Guo JM, Xu CF, et al. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Clin Chim Acta,2005,361(1-2):119-127.
-
7Coon PK, Boos CJ, Stonelake PS, et al. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads:a methodological comparison. Thromb Haemost, 2006,96:45-52.
-
8Guo J, Xiao B, Jin Z, et al. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction. J Gastroenterol Hepatol, 2005,20:1279-1284.
-
9Kashima K, Nanashima A, Yasutake T, et al. Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization. Anticancer Res, 2006,26(4B):2849-2855.
-
10Kumar V, Varma N, Varma S, et al. Flow cytometric analysis of DNA indices, expression of p53 and multidrug resistance genes in multiple myeloma patients. Anal Quant Cytol Histol, 2004,26:271-277.
引证文献3
-
1楼燕如,郭俊明,于利勇,陈晓岗,袁旦平,胡文涛,黄小萍,牧启田,叶刚,励新健,梁伟,张怡.免疫磁珠与DNA倍体检测肿瘤患者外周血中癌细胞的初步临床应用[J].中华检验医学杂志,2008,31(2):179-181.
-
2张捷,张英兰,陈晓华.KAI1/CD82在肠癌组织中的表达水平及表达机制[J].临床检验杂志,2002,20(3):153-155. 被引量:2
-
3张捷,陈晓华.KAI_1在原发性肝癌组织中的表达水平及调控机制的初探[J].中国实验诊断学,2003,7(3):234-237. 被引量:4
二级引证文献6
-
1陈继安,梁安民,罗小玲.KAI1/CD82与肝癌关系的研究进展[J].中国医学文摘(肿瘤学),2006,20(1):70-71.
-
2吴春利,耿小平,朱立新.KAI1/CD82与肝细胞癌转移相关性的研究进展[J].实用肝脏病杂志,2008,11(5):345-349. 被引量:2
-
3徐广敏,龙艳丽.去甲基化药物对胃癌细胞中KAI1基因表达水平影响初探[J].广东医学,2017,38(19):2931-2933. 被引量:2
-
4张捷,陈晓华.KAI_1在原发性肝癌组织中的表达水平及调控机制的初探[J].中国实验诊断学,2003,7(3):234-237. 被引量:4
-
5任丽楠,刘民培,郭晓钟,徐建华,安天义.KAI1基因在胰腺癌中抗转移作用的研究[J].世界华人消化杂志,2003,11(7):1046-1049. 被引量:4
-
6侯茂林,张秋杰.胃癌相关抑癌基因在肝转移中的研究现状及进展[J].临床医学进展,2022,12(8):7172-7180.
-
1呼闯营,戴晓波,唐文,王少峰.胰腺癌77例临床分析[J].苏州大学学报(医学版),2006,26(4):671-672. 被引量:3
-
2黄聪武,贝濂,刘挺.CA_(50)、CA_(242)诊断消化系统恶性肿瘤的临床价值[J].中国医学科学院学报,1998,20(4):285-288. 被引量:5
-
3石青峰,罗云.6种肿瘤标志物联合检测在胰腺癌诊断中的价值[J].广西医科大学学报,2006,23(5):782-783. 被引量:3
-
4容小翔.家庭中的致癌物[J].抗癌,2005(4):7-8.
-
5王戊辰,周永宁.肿瘤相关抗原及抗体在肝癌诊断中的研究进展[J].临床肝胆病杂志,2014,30(6):573-576. 被引量:3
-
6Reiniger I.W.,SchallerU.C.,HaritoglouC.,陈立军.黑色素瘤抑制蛋白有望成为转移性葡萄膜黑色素瘤的肿瘤血清学标记物[J].世界核心医学期刊文摘(眼科学分册),2006,2(5):38-39.
-
7齐岩,石红,张新宇.CA125、CA153及CEA联合检测对卵巢癌的诊断价值[J].中国实验诊断学,2010,14(12):2027-2028. 被引量:6
-
8张齐(综述),石欣(审校),范健(审校).胰腺癌的早期诊断[J].国际肿瘤学杂志,2007,34(2):131-134. 被引量:3
-
9陈永伟,朱亚妮,殷政芳,肖华龙.TSGF与AFP,CEA联检对恶性肿瘤诊断意义的评价[J].放射免疫学杂志,2001,14(5):318-319. 被引量:7
-
10费苛.常见但鲜为人知的胸部肿瘤[J].大众医学,2011(11):26-26.